Drug · DIN 02520702
ESOMEPRAZOLE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 28, 2022; first marketed June 28, 2022.
- Drug Identification Number (DIN)
- 02520702
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Esomeprazole A02BC05
- Class
- Human
- Record last updated
- December 16, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 23, 2021: NOC 26705Abbreviated New Drug Submission (ANDS) · Licensing Agreement Between Two Companies
Other DINs named ESOMEPRAZOLE
- DIN 02394839 · Marketed
- DIN 02394847 · Marketed
- DIN 02442493 · Marketed
- DIN 02442507 · Marketed
- DIN 02520699 · Marketed
- DIN 02417480 · Approved
- DIN 02417499 · Approved
- DIN 02431173 · Dormant
- DIN 02438461 · Cancelled Pre Market
- DIN 02438488 · Cancelled Pre Market
- DIN 02449587 · Cancelled Pre Market
- DIN 02449595 · Cancelled Pre Market
- DIN 02535335 · Dormant